Choose Language
Select a language for news translation.
Written by Josh Kohn-Lindquist for The Motley Fool Moderna (NASDAQ:MRNA) , an mRNA medicine and preventive vaccines provider, closed at $174.38, up 176.97%. S…
Written by Jeremy Bowman for The Motley Fool Key Points Target's turnaround gained momentum after the company reported 3.6% comparable sales in Q2. The retail…
Written by Robert Izquierdo for The Motley Fool Key Points The shares were sold for a total consideration of ~$214,127 at a weighted average price of $109.36 …
Written by John Ballard for The Motley Fool Key Points The disposition involved 17,151 shares valued at $634,587 based on the transaction-date weighted averag…
Written by Neil Patel for The Motley Fool Key Points Nu's profits are surging as it gains millions of new customers. Credit cards and unsecured loans make up …
Written by Jonathan Ponciano for The Motley Fool Key Points The disposition involved 6,490 shares worth about $183,000 at a price of $28.15 per share on Augus…
Written by Chris Neiger for The Motley Fool Key Points D-Wave's bookings jumped 1,120% in the second quarter to $36 million. D-Wave's stock is outlandishly ex…
Written by Robert Izquierdo for The Motley Fool Key Points When evaluating the revenue performance of the two companies, Lumentum currently demonstrates a con…
Written by Parkev Tatevosian for The Motley Fool Apple (NASDAQ: AAPL) is working to expand its reach. Missed Nvidia in 2009? This Rare Signal Is Flashing Agai…
Written by Brendan Coffey for The Motley Fool Key Points State Street SPDR S&P Oil & Gas Exploration & Production ETF is more cost-efficient with an expense r…
Written by David Jagielski for The Motley Fool Key Points Broadcom's strong relationship with hyperscalers puts it in a great position to benefit from high sp…
